Melanoma gp100 antibody (AA 376-502)
Quick Overview for Melanoma gp100 antibody (AA 376-502) (ABIN7874471)
Target
See all Melanoma gp100 (PMEL) AntibodiesReactivity
Host
Clonality
Conjugate
Application
Grade
Clone
-
-
Binding Specificity
- AA 376-502
-
Purpose
- Melanoma gp100 Antibody / PMEL17 (azide and preservative free)
-
Purification
- Protein G affinity chromatography
-
Immunogen
- A portion of amino acids 376-502 from the human protein was used as the immunogen for the Melanoma gp100 antibody.
-
Isotype
- IgG1, kappa
-
-
-
-
Application Notes
- The stated application concentrations are suggested starting points. Titration of the Melanoma gp100 antibody may be required due to differences in protocols and secondary/substrate sensitivity.
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- 1 mg/mL
-
Buffer
- 1 mg/mL in 1X PBS, BSA free, sodium azide free
-
Preservative
- Azide free
-
Storage
- 4 °C,-20 °C
-
Storage Comment
- Store the Melanoma gp100 antibody at 2-8oC (with azide) or aliquot and store at -20oC or colder (without azide).
-
-
- Melanoma gp100 (PMEL) (Premelanosome Protein (PMEL))
-
Alternative Name
- Melanoma gp100
-
Background
- PMEL17/Melanoma gp100/SILV plays a central role in the biogenesis of melanosomes. Involved in the maturation of melanosomes from stage I to II. The transition from stage I melanosomes to stage II melanosomes involves an elongation of the vesicle, and the appearance within of distinct fibrillar structures. Release of the soluble form, ME20-S, could protect tumor cells from antibody mediated immunity. [UniProt]
-
UniProt
- P40967
Target
-